FDA offers support for Pfizer, Moderna Covid-19 vaccines for the youngest children ahead of adcomm
As the majority of parents of children under 12 who can be vaccinated against Covid-19 still decide against it — just 36% of 5-11 year-olds are vaccinated, according to the AAP — the FDA over the past several days laid out its case for why EUAs should be expanded for both the Moderna and Pfizer/BioNTech vaccines to the youngest children of 6 months to 5 years.
The FDA’s VRBPAC will meet tomorrow and Wednesday to review the latest data and offer some perspective on the agency’s briefing documents, which seem to signal a likely EUA for both Moderna and Pfizer/BioNTech in these populations.
Keep reading Endpoints with a free subscription
Unlock this story instantly and join 144,400+ biopharma pros reading Endpoints daily — and it's free.